Tharimmune Inc. (THAR)
Tharimmune Statistics
Share Statistics
Tharimmune has 1.49M shares outstanding. The number of shares has increased by -87.34% in one year.
Shares Outstanding | 1.49M |
Shares Change (YoY) | -87.34% |
Shares Change (QoQ) | 29.36% |
Owned by Institutions (%) | n/a |
Shares Floating | 1.46M |
Failed to Deliver (FTD) Shares | 16.85K |
FTD / Avg. Volume | 17.83% |
Short Selling Information
The latest short interest is 54.23K, so 3.65% of the outstanding shares have been sold short.
Short Interest | 54.23K |
Short % of Shares Out | 3.65% |
Short % of Float | 3.71% |
Short Ratio (days to cover) | 1.06 |
Valuation Ratios
The PE ratio is -0.07 and the forward PE ratio is -16.5. Tharimmune's PEG ratio is 0.
PE Ratio | -0.07 |
Forward PE | -16.5 |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 0.07 |
P/FCF Ratio | -0.09 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tharimmune Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.03, with a Debt / Equity ratio of 0.
Current Ratio | 6.03 |
Quick Ratio | 6.03 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | -572.87 |
Financial Efficiency
Return on equity (ROE) is -1.02% and return on capital (ROIC) is -103.55%.
Return on Equity (ROE) | -1.02% |
Return on Assets (ROA) | -0.85% |
Return on Capital (ROIC) | -103.55% |
Revenue Per Employee | $0 |
Profits Per Employee | $-4,659,547 |
Employee Count | 2 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -75.17% in the last 52 weeks. The beta is 1.27, so Tharimmune's price volatility has been higher than the market average.
Beta | 1.27 |
52-Week Price Change | -75.17% |
50-Day Moving Average | 1.96 |
200-Day Moving Average | 2.78 |
Relative Strength Index (RSI) | 29.47 |
Average Volume (20 Days) | 94.51K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -9.46M |
Net Income | -9.32M |
EBITDA | -9.3M |
EBIT | n/a |
Earnings Per Share (EPS) | -107.08 |
Balance Sheet
The company has 10.94M in cash and 0 in debt, giving a net cash position of 10.94M.
Cash & Cash Equivalents | 10.94M |
Total Debt | 0 |
Net Cash | 10.94M |
Retained Earnings | -24.7M |
Total Assets | 5.25M |
Working Capital | 3.02M |
Cash Flow
In the last 12 months, operating cash flow was -7.3M and capital expenditures -4, giving a free cash flow of -7.3M.
Operating Cash Flow | -7.3M |
Capital Expenditures | -4 |
Free Cash Flow | -7.3M |
FCF Per Share | -83.88 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
THAR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -7540.85% |
FCF Yield | -345.95% |
Analyst Forecast
The average price target for THAR is $17, which is 1097.2% higher than the current price. The consensus rating is "Buy".
Price Target | $17 |
Price Target Difference | 1097.2% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Stock Splits
The last stock split was on May 28, 2024. It was a backward split with a ratio of 1:15.
Last Split Date | May 28, 2024 |
Split Type | backward |
Split Ratio | 1:15 |
Scores
Altman Z-Score | -14.44 |
Piotroski F-Score | 2 |